Skip to content

Fortrea Holdings

US · FTRE #2796 by market cap Listed 2023
20.56 -0.22 -1.06%
Live - 5344 symbols - heartbeat 500s ago · 2026-10-08 04:52
Pre-market 20.93 +1.81%
After-hours 20.56 0.00%
Market cap
1.96B
P/B
3.73
EPS
-10.81
Reader sentiment Are you bullish or bearish on FTRE?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $23
    Market Newswire · 2026/8/4
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)
    TipRanks · 2026/7/30
  • Rating change
    A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $22 to $26
    Market Newswire · 2026/7/31
  • UBS Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $22
    Market Newswire · 2026/9/30
  • Rating change
    TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $23
    Market Newswire · 2026/8/4
  • Rating change
    Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/9/3
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/8/4
  • Rating change
    Truist Financial Remains a Buy on Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/7/30
  • Rating change
    Barclays Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/7/30
  • Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
    Market Newswire · 2026/9/3
  • Rating change
    Citi Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Announces Target Price $22
    Market Newswire · 2026/7/31
  • Rating change
    William Blair Maintains Fortrea Holdings(FTRE.US) With Hold Rating
    Market Newswire · 2026/9/10
  • UBS Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
    Market Newswire · 2026/10/3
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/7/31
  • Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy Rating
    Market Newswire · 2026/9/3
  • Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)
    TipRanks · 2026/9/10
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)
    TipRanks · 2026/8/17
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
    TipRanks · 2026/9/2
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/9/3

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 04:52:21 · For reference only, not investment advice and not tailored to your situation.